Renal Denervation System Receives EU Green Light

Published date : 05 February 2013
Article date : 05 February 2013


Medgadget reports that ReCor Medical, manufacturers of the ultrasound based renal denervation system for control of hypertension has received clearance for its PARADISE Gen 2 device from EU authorities. The original system was approved for sale a year ago and the new system provides an over-the-wire 6Fr device size and faster denervation.

“Our unique approach is in stark contrast to RF, which is limited in its depth of penetration to just a few millimeters, due to inconsistent arterial wall contact, as well as its inability to heat circumferentially in any given location,” said Iyer. “In addition, RF technologies generate unnecessary heating at the level of the arterial wall. Data presented at TCT 2012 concluded that renal nerves are actually much further at depth than previously thought, and run circumferentially around the renal arteries, which underscores the PARADISE ultrasound advantage.”

Source: Gene Ostrovsky, Medgdget, 29 January 2013 

ReCor Medical  Paradise Renal Denervation System | Used in Renal denervation | Which Medical Device
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.